Search

Search Constraints

You searched for: Author/Creator Musaazi, Joseph

Search Results

1. Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study. Issue 9 (18th September 2017)

2. Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin. (21st July 2022)

3. Delayed Sputum Culture Conversion in Tuberculosis–Human Immunodeficiency Virus–Coinfected Patients With Low Isoniazid and Rifampicin Concentrations. (3rd March 2018)

7. Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial. Issue 6 (June 2022)

9. Loss to follow‐up among children and adolescents growing up with HIV infection: age really matters. Issue 1 (17th July 2017)

10. Nutritional status and its associated factors among HIV adolescents on second line regimen at Pediatric Infectious Diseases Clinic in Uganda. Issue 1 (2nd January 2022)